Danny Burke, CEO of ecancer, shared a post on LinkedIn:
“For the latest developments in EGFR-positive NSCLC, hear from leading experts Enriqueta Felip, Antonio Passaro, Alex Spira, and Ignacio Gil-Bazo. In this video, they share their interpretation of the latest from the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC 2025).”
More posts featuring Danny Burke.